Subscribe To
November 2023 Letter to Shareholders
VANCOUVER, Washington, Nov. 03, 2023 (GLOBE NEWSWIRE) — Dear Shareholders, We write to provide an update on CytoDyn Inc. (“CytoDyn” or “Company”), and to thank you for your continued support of the Company. Throughout our history, CytoDyn has made great strides in developing leronlimab from a single indication molecule into a platform molecule with the […] The post November 2023 Letter to Shareholders appeared first on ForexTV...
Read More
Posted: Nov 3 2023, 20:02
Author Name: forextv
Views: 112310